I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Poklepovic, Andrew S.
20
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Adva..:
Patel, Sapna P
;
Othus, Megan
;
Chen, Yuanbin
...
qt87x612c2. , 2023
Link:
https://escholarship.org..
?
2
Immunologically programming the tumor microenvironment indu..:
Yu, Xiaofei
;
Liu, Wenjie
;
Chen, Shixian
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817794/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
3
A Multi-Institutional Phase 2 Trial of Regorafenib in Refra..:
Kim, Richard D
;
Sanoff, Hanna K
;
Poklepovic, Andrew S
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787270/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
4
Considering adjuvant therapy for stage II melanoma:
Poklepovic, Andrew S
;
Luke, Jason J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065103/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
5
777 Initial results from an open-label phase 1b/2 study of ..:
Gregory A Daniels
;
Diwakar Davar
;
Theresa Medina
...
https://doaj.org/toc/2051-1426. , 2023
Link:
https://doi.org/10.1136/..
?
6
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infil..:
Gino K In
;
James Larkin
;
Yazan Samhouri
...
https://doaj.org/toc/2051-1426. , 2023
Link:
https://doi.org/10.1136/..
?
7
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in ..:
Stacey A. Cohen
;
Anup Kasi
;
Nicole Hook
...
http://dx.doi.org/10.1155/2022/9412201. , 2022
Link:
https://doi.org/10.1155/..
?
8
Immunologically programming the tumor microenvironment indu..:
Elizabeth Repasky
;
Harry D Bear
;
Fang Yuan
...
https://jitc.bmj.com/content/9/1/e001595.full. , 2021
Link:
https://doi.org/10.1136/..
?
9
BMI, irAE, and gene expression signatures associate with re..:
Brian W. Labadie
;
Ping Liu
;
Riyue Bao
...
http://link.springer.com/article/10.1186/s12967-019-02144-7. , 2019
Link:
https://doi.org/10.1186/..
?
10
Multicenter randomized phase II trial of atezolizumab with ..:
Yarchoan, Mark
;
Cope, Leslie
;
Ruggieri, Amanda N
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670844/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
11
Multicenter randomized phase II trial of atezolizumab with ..:
Yarchoan, Mark
;
Cope, Leslie
;
Ruggieri, Amanda N
...
qt3w93z8gj. , 2021
Link:
https://escholarship.org..
?
12
Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RA..:
Dent, Paul
;
Booth, Laurence
;
Roberts, Jane L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133220/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
13
The irreversible ERBB1/2/4 inhibitor neratinib interacts wi..:
Booth, Laurence
;
Roberts, Jane L
;
Samuel, Peter
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927661/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
14
The irreversible ERBB1/2/4 inhibitor neratinib interacts wi..:
Booth, Laurence
;
Roberts, Jane L
;
Avogadri-Connors, Francesca
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986350/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
15
Neratinib and entinostat combine to rapidly reduce the expr..:
Booth, Laurence
;
Roberts, Jane L
;
Sander, Cindy
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606002/. , 2018
Link:
http://www.ncbi.nlm.nih...
1-15